nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—germ cell cancer—melanoma	0.258	0.527	CtDrD
Cisplatin—lung cancer—melanoma	0.232	0.473	CtDrD
Cisplatin—ABCC6—Dactinomycin—melanoma	0.116	0.55	CbGbCtD
Cisplatin—PTGS2—melanoma	0.0611	0.541	CbGaD
Cisplatin—ABCB1—melanoma	0.0519	0.46	CbGaD
Cisplatin—ABCG2—Vemurafenib—melanoma	0.0345	0.163	CbGbCtD
Cisplatin—ABCG2—Dactinomycin—melanoma	0.0229	0.109	CbGbCtD
Cisplatin—ABCC2—Docetaxel—melanoma	0.0131	0.062	CbGbCtD
Cisplatin—ABCG2—Docetaxel—melanoma	0.0118	0.0561	CbGbCtD
Cisplatin—ABCB1—Dactinomycin—melanoma	0.00826	0.0392	CbGbCtD
Cisplatin—ABCB1—Docetaxel—melanoma	0.00427	0.0202	CbGbCtD
Cisplatin—ABCC6—dermis—melanoma	0.00406	0.105	CbGeAlD
Cisplatin—SLC31A2—hair follicle—melanoma	0.00151	0.0391	CbGeAlD
Cisplatin—ATP7A—endothelium—melanoma	0.00135	0.035	CbGeAlD
Cisplatin—ATP7A—hair follicle—melanoma	0.00133	0.0344	CbGeAlD
Cisplatin—ATP7A—blood vessel—melanoma	0.00124	0.0323	CbGeAlD
Cisplatin—SOD1—hair follicle—melanoma	0.00116	0.0301	CbGeAlD
Cisplatin—SLC31A1—hair follicle—melanoma	0.00113	0.0294	CbGeAlD
Cisplatin—GSTM1—blood vessel—melanoma	0.00104	0.0269	CbGeAlD
Cisplatin—GSTT1—neck—melanoma	0.00101	0.0261	CbGeAlD
Cisplatin—ABCC5—hair follicle—melanoma	0.000827	0.0215	CbGeAlD
Cisplatin—MT2A—eye—melanoma	0.000765	0.0198	CbGeAlD
Cisplatin—GSTM1—neck—melanoma	0.000741	0.0192	CbGeAlD
Cisplatin—MPO—endothelium—melanoma	0.000724	0.0188	CbGeAlD
Cisplatin—PTGS2—leg—melanoma	0.00071	0.0184	CbGeAlD
Cisplatin—GSTP1—hair follicle—melanoma	0.000692	0.018	CbGeAlD
Cisplatin—MPO—blood vessel—melanoma	0.000667	0.0173	CbGeAlD
Cisplatin—MT2A—skin of body—melanoma	0.000665	0.0173	CbGeAlD
Cisplatin—PTGS2—hindlimb—melanoma	0.000634	0.0164	CbGeAlD
Cisplatin—ABCC6—eye—melanoma	0.000607	0.0158	CbGeAlD
Cisplatin—ABCC6—retina—melanoma	0.000602	0.0156	CbGeAlD
Cisplatin—SLC31A2—mammalian vulva—melanoma	0.000596	0.0155	CbGeAlD
Cisplatin—PTGS2—appendage—melanoma	0.000544	0.0141	CbGeAlD
Cisplatin—ATP7A—mammalian vulva—melanoma	0.000525	0.0136	CbGeAlD
Cisplatin—NQO1—neck—melanoma	0.000519	0.0135	CbGeAlD
Cisplatin—GSTM1—skin of body—melanoma	0.00048	0.0124	CbGeAlD
Cisplatin—ATP7B—head—melanoma	0.000467	0.0121	CbGeAlD
Cisplatin—GSTP1—neck—melanoma	0.000464	0.012	CbGeAlD
Cisplatin—SOD1—mammalian vulva—melanoma	0.00046	0.0119	CbGeAlD
Cisplatin—PTGS2—skin epidermis—melanoma	0.000452	0.0117	CbGeAlD
Cisplatin—SLC31A1—mammalian vulva—melanoma	0.000448	0.0116	CbGeAlD
Cisplatin—XDH—mammalian vulva—melanoma	0.000443	0.0115	CbGeAlD
Cisplatin—MT2A—head—melanoma	0.000434	0.0113	CbGeAlD
Cisplatin—SLC31A2—head—melanoma	0.000427	0.0111	CbGeAlD
Cisplatin—GSTT1—head—melanoma	0.000425	0.011	CbGeAlD
Cisplatin—ABCC5—retina—melanoma	0.000409	0.0106	CbGeAlD
Cisplatin—NQO1—eye—melanoma	0.000386	0.01	CbGeAlD
Cisplatin—NQO1—retina—melanoma	0.000383	0.00994	CbGeAlD
Cisplatin—MT1A—lymph node—melanoma	0.000365	0.00947	CbGeAlD
Cisplatin—GSTP1—eye—melanoma	0.000345	0.00896	CbGeAlD
Cisplatin—ABCC6—head—melanoma	0.000345	0.00895	CbGeAlD
Cisplatin—GSTP1—retina—melanoma	0.000342	0.00888	CbGeAlD
Cisplatin—NQO1—skin of body—melanoma	0.000336	0.00872	CbGeAlD
Cisplatin—PTGS2—endothelium—melanoma	0.000328	0.00852	CbGeAlD
Cisplatin—ATP7B—lymph node—melanoma	0.000327	0.00848	CbGeAlD
Cisplatin—SLC31A1—head—melanoma	0.000321	0.00832	CbGeAlD
Cisplatin—GSTM1—head—melanoma	0.000313	0.00812	CbGeAlD
Cisplatin—MPO—skin of body—melanoma	0.000309	0.00802	CbGeAlD
Cisplatin—NQO1—mammalian vulva—melanoma	0.000307	0.00795	CbGeAlD
Cisplatin—PTGS2—blood vessel—melanoma	0.000303	0.00785	CbGeAlD
Cisplatin—GSTP1—skin of body—melanoma	0.0003	0.00779	CbGeAlD
Cisplatin—SLC31A2—lymph node—melanoma	0.000299	0.00775	CbGeAlD
Cisplatin—GSTP1—mammalian vulva—melanoma	0.000274	0.00711	CbGeAlD
Cisplatin—ATP7A—lymph node—melanoma	0.000263	0.00683	CbGeAlD
Cisplatin—Deafness—Temozolomide—melanoma	0.000239	0.00337	CcSEcCtD
Cisplatin—Amnesia—Carmustine—melanoma	0.000236	0.00332	CcSEcCtD
Cisplatin—Nasal congestion—Temozolomide—melanoma	0.000235	0.00331	CcSEcCtD
Cisplatin—SOD1—lymph node—melanoma	0.00023	0.00598	CbGeAlD
Cisplatin—Amnesia—Temozolomide—melanoma	0.000228	0.00321	CcSEcCtD
Cisplatin—Extravasation—Docetaxel—melanoma	0.000225	0.00317	CcSEcCtD
Cisplatin—SLC31A1—lymph node—melanoma	0.000224	0.00583	CbGeAlD
Cisplatin—Hyponatraemia—Carmustine—melanoma	0.000222	0.00313	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Carmustine—melanoma	0.000221	0.00312	CcSEcCtD
Cisplatin—NQO1—head—melanoma	0.000219	0.00569	CbGeAlD
Cisplatin—GSTM1—lymph node—melanoma	0.000219	0.00569	CbGeAlD
Cisplatin—Myalgia—Vemurafenib—melanoma	0.000215	0.00303	CcSEcCtD
Cisplatin—Face oedema—Carmustine—melanoma	0.000214	0.00301	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000213	0.00301	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000213	0.003	CcSEcCtD
Cisplatin—Pancytopenia—Bleomycin—melanoma	0.000208	0.00294	CcSEcCtD
Cisplatin—Face oedema—Temozolomide—melanoma	0.000207	0.00291	CcSEcCtD
Cisplatin—Hearing impaired—Docetaxel—melanoma	0.000206	0.0029	CcSEcCtD
Cisplatin—Anaphylactic shock—Vemurafenib—melanoma	0.000206	0.0029	CcSEcCtD
Cisplatin—Infection—Vemurafenib—melanoma	0.000204	0.00288	CcSEcCtD
Cisplatin—Nervous system disorder—Vemurafenib—melanoma	0.000202	0.00285	CcSEcCtD
Cisplatin—MPO—head—melanoma	0.000202	0.00523	CbGeAlD
Cisplatin—Hypokalaemia—Carmustine—melanoma	0.000202	0.00284	CcSEcCtD
Cisplatin—Skin disorder—Vemurafenib—melanoma	0.0002	0.00282	CcSEcCtD
Cisplatin—Dehydration—Temozolomide—melanoma	0.000199	0.00281	CcSEcCtD
Cisplatin—ABCC3—head—melanoma	0.000197	0.00511	CbGeAlD
Cisplatin—Hepatocellular injury—Docetaxel—melanoma	0.000196	0.00276	CcSEcCtD
Cisplatin—GSTP1—head—melanoma	0.000196	0.00509	CbGeAlD
Cisplatin—Hypokalaemia—Temozolomide—melanoma	0.000195	0.00275	CcSEcCtD
Cisplatin—Pancytopenia—Dactinomycin—melanoma	0.000194	0.00274	CcSEcCtD
Cisplatin—Breast disorder—Temozolomide—melanoma	0.000193	0.00273	CcSEcCtD
Cisplatin—Acute coronary syndrome—Bleomycin—melanoma	0.000193	0.00272	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000193	0.00272	CcSEcCtD
Cisplatin—Hypotension—Vemurafenib—melanoma	0.000192	0.00271	CcSEcCtD
Cisplatin—Myocardial infarction—Bleomycin—melanoma	0.000192	0.0027	CcSEcCtD
Cisplatin—Stomatitis—Bleomycin—melanoma	0.000191	0.00269	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000188	0.00264	CcSEcCtD
Cisplatin—ABCB1—blood vessel—melanoma	0.000187	0.00486	CbGeAlD
Cisplatin—Skin exfoliation—Docetaxel—melanoma	0.000187	0.00264	CcSEcCtD
Cisplatin—Fluid retention—Docetaxel—melanoma	0.000186	0.00262	CcSEcCtD
Cisplatin—Neuropathy—Docetaxel—melanoma	0.000184	0.0026	CcSEcCtD
Cisplatin—BCHE—skin of body—melanoma	0.000182	0.00472	CbGeAlD
Cisplatin—Pancytopenia—Carmustine—melanoma	0.000182	0.00256	CcSEcCtD
Cisplatin—Sweating increased—Temozolomide—melanoma	0.00018	0.00254	CcSEcCtD
Cisplatin—Decreased appetite—Vemurafenib—melanoma	0.000179	0.00252	CcSEcCtD
Cisplatin—Stomatitis—Dactinomycin—melanoma	0.000178	0.00251	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000178	0.00251	CcSEcCtD
Cisplatin—Pancytopenia—Temozolomide—melanoma	0.000176	0.00248	CcSEcCtD
Cisplatin—Renal failure—Carmustine—melanoma	0.000168	0.00237	CcSEcCtD
Cisplatin—Neuropathy peripheral—Carmustine—melanoma	0.000167	0.00236	CcSEcCtD
Cisplatin—Stomatitis—Carmustine—melanoma	0.000166	0.00235	CcSEcCtD
Cisplatin—BCHE—mammalian vulva—melanoma	0.000166	0.0043	CbGeAlD
Cisplatin—Phlebitis—Docetaxel—melanoma	0.000165	0.00233	CcSEcCtD
Cisplatin—ABCC5—lymph node—melanoma	0.000164	0.00426	CbGeAlD
Cisplatin—Flushing—Bleomycin—melanoma	0.000163	0.0023	CcSEcCtD
Cisplatin—Body temperature increased—Vemurafenib—melanoma	0.000163	0.00229	CcSEcCtD
Cisplatin—CYP2B6—skin of body—melanoma	0.000162	0.00421	CbGeAlD
Cisplatin—Neuropathy peripheral—Temozolomide—melanoma	0.000162	0.00228	CcSEcCtD
Cisplatin—Stomatitis—Temozolomide—melanoma	0.000161	0.00227	CcSEcCtD
Cisplatin—ABCG2—mammalian vulva—melanoma	0.00016	0.00416	CbGeAlD
Cisplatin—Deafness—Docetaxel—melanoma	0.000159	0.00224	CcSEcCtD
Cisplatin—Cardiac failure congestive—Docetaxel—melanoma	0.000157	0.00221	CcSEcCtD
Cisplatin—Hepatobiliary disease—Temozolomide—melanoma	0.000156	0.0022	CcSEcCtD
Cisplatin—Alopecia—Bleomycin—melanoma	0.000155	0.00219	CcSEcCtD
Cisplatin—NQO1—lymph node—melanoma	0.000154	0.00398	CbGeAlD
Cisplatin—Erythema—Bleomycin—melanoma	0.000153	0.00215	CcSEcCtD
Cisplatin—Flushing—Dactinomycin—melanoma	0.000152	0.00214	CcSEcCtD
Cisplatin—Hypersensitivity—Vemurafenib—melanoma	0.000152	0.00214	CcSEcCtD
Cisplatin—Connective tissue disorder—Carmustine—melanoma	0.000151	0.00212	CcSEcCtD
Cisplatin—Asthenia—Vemurafenib—melanoma	0.000148	0.00208	CcSEcCtD
Cisplatin—Visual impairment—Carmustine—melanoma	0.000148	0.00208	CcSEcCtD
Cisplatin—Urinary tract disorder—Temozolomide—melanoma	0.000146	0.00206	CcSEcCtD
Cisplatin—Connective tissue disorder—Temozolomide—melanoma	0.000145	0.00205	CcSEcCtD
Cisplatin—Urethral disorder—Temozolomide—melanoma	0.000145	0.00205	CcSEcCtD
Cisplatin—Alopecia—Dactinomycin—melanoma	0.000145	0.00204	CcSEcCtD
Cisplatin—Eye disorder—Carmustine—melanoma	0.000143	0.00202	CcSEcCtD
Cisplatin—Hyponatraemia—Docetaxel—melanoma	0.000143	0.00201	CcSEcCtD
Cisplatin—Visual impairment—Temozolomide—melanoma	0.000143	0.00201	CcSEcCtD
Cisplatin—Erythema—Dactinomycin—melanoma	0.000142	0.00201	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000142	0.00201	CcSEcCtD
Cisplatin—Flushing—Carmustine—melanoma	0.000142	0.002	CcSEcCtD
Cisplatin—Ill-defined disorder—Bleomycin—melanoma	0.000142	0.002	CcSEcCtD
Cisplatin—Anaemia—Bleomycin—melanoma	0.000141	0.00199	CcSEcCtD
Cisplatin—MPO—lymph node—melanoma	0.000141	0.00366	CbGeAlD
Cisplatin—Diarrhoea—Vemurafenib—melanoma	0.000141	0.00199	CcSEcCtD
Cisplatin—PTGS2—skin of body—melanoma	0.00014	0.00364	CbGeAlD
Cisplatin—Eye disorder—Temozolomide—melanoma	0.000138	0.00195	CcSEcCtD
Cisplatin—Tinnitus—Temozolomide—melanoma	0.000138	0.00195	CcSEcCtD
Cisplatin—ABCC3—lymph node—melanoma	0.000138	0.00358	CbGeAlD
Cisplatin—Malaise—Bleomycin—melanoma	0.000138	0.00194	CcSEcCtD
Cisplatin—Flushing—Temozolomide—melanoma	0.000137	0.00194	CcSEcCtD
Cisplatin—Cardiac disorder—Temozolomide—melanoma	0.000137	0.00194	CcSEcCtD
Cisplatin—GSTP1—lymph node—melanoma	0.000137	0.00356	CbGeAlD
Cisplatin—Arrhythmia—Carmustine—melanoma	0.000137	0.00193	CcSEcCtD
Cisplatin—Leukopenia—Bleomycin—melanoma	0.000137	0.00193	CcSEcCtD
Cisplatin—Alopecia—Carmustine—melanoma	0.000135	0.00191	CcSEcCtD
Cisplatin—Immune system disorder—Temozolomide—melanoma	0.000134	0.00189	CcSEcCtD
Cisplatin—Mediastinal disorder—Temozolomide—melanoma	0.000133	0.00188	CcSEcCtD
Cisplatin—Malnutrition—Carmustine—melanoma	0.000133	0.00188	CcSEcCtD
Cisplatin—Erythema—Carmustine—melanoma	0.000133	0.00188	CcSEcCtD
Cisplatin—Dehydration—Docetaxel—melanoma	0.000132	0.00187	CcSEcCtD
Cisplatin—Ill-defined disorder—Dactinomycin—melanoma	0.000132	0.00186	CcSEcCtD
Cisplatin—Anaemia—Dactinomycin—melanoma	0.000132	0.00186	CcSEcCtD
Cisplatin—Vomiting—Vemurafenib—melanoma	0.000131	0.00185	CcSEcCtD
Cisplatin—Alopecia—Temozolomide—melanoma	0.000131	0.00184	CcSEcCtD
Cisplatin—Myalgia—Bleomycin—melanoma	0.00013	0.00183	CcSEcCtD
Cisplatin—Orthostatic hypotension—Docetaxel—melanoma	0.00013	0.00183	CcSEcCtD
Cisplatin—Rash—Vemurafenib—melanoma	0.00013	0.00183	CcSEcCtD
Cisplatin—Dermatitis—Vemurafenib—melanoma	0.00013	0.00183	CcSEcCtD
Cisplatin—Erythema—Temozolomide—melanoma	0.000129	0.00182	CcSEcCtD
Cisplatin—Malnutrition—Temozolomide—melanoma	0.000129	0.00182	CcSEcCtD
Cisplatin—Breast disorder—Docetaxel—melanoma	0.000129	0.00181	CcSEcCtD
Cisplatin—Discomfort—Bleomycin—melanoma	0.000129	0.00181	CcSEcCtD
Cisplatin—Malaise—Dactinomycin—melanoma	0.000129	0.00181	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000128	0.00181	CcSEcCtD
Cisplatin—Cramp muscle—Docetaxel—melanoma	0.000128	0.00181	CcSEcCtD
Cisplatin—Leukopenia—Dactinomycin—melanoma	0.000128	0.0018	CcSEcCtD
Cisplatin—Nasopharyngitis—Docetaxel—melanoma	0.000127	0.00179	CcSEcCtD
Cisplatin—Vision blurred—Carmustine—melanoma	0.000126	0.00177	CcSEcCtD
Cisplatin—Tremor—Carmustine—melanoma	0.000125	0.00176	CcSEcCtD
Cisplatin—Anaphylactic shock—Bleomycin—melanoma	0.000125	0.00176	CcSEcCtD
Cisplatin—Oedema—Bleomycin—melanoma	0.000125	0.00176	CcSEcCtD
Cisplatin—Infection—Bleomycin—melanoma	0.000124	0.00175	CcSEcCtD
Cisplatin—Anaemia—Carmustine—melanoma	0.000123	0.00174	CcSEcCtD
Cisplatin—Nausea—Vemurafenib—melanoma	0.000122	0.00172	CcSEcCtD
Cisplatin—Thrombocytopenia—Bleomycin—melanoma	0.000122	0.00172	CcSEcCtD
Cisplatin—Vision blurred—Temozolomide—melanoma	0.000121	0.00171	CcSEcCtD
Cisplatin—Myalgia—Dactinomycin—melanoma	0.000121	0.00171	CcSEcCtD
Cisplatin—Tremor—Temozolomide—melanoma	0.000121	0.0017	CcSEcCtD
Cisplatin—Discomfort—Dactinomycin—melanoma	0.00012	0.00169	CcSEcCtD
Cisplatin—Ill-defined disorder—Temozolomide—melanoma	0.00012	0.00169	CcSEcCtD
Cisplatin—Leukopenia—Carmustine—melanoma	0.000119	0.00168	CcSEcCtD
Cisplatin—Anaemia—Temozolomide—melanoma	0.000119	0.00168	CcSEcCtD
Cisplatin—Anorexia—Bleomycin—melanoma	0.000119	0.00168	CcSEcCtD
Cisplatin—BCHE—head—melanoma	0.000119	0.00308	CbGeAlD
Cisplatin—Pancytopenia—Docetaxel—melanoma	0.000117	0.00165	CcSEcCtD
Cisplatin—Hypotension—Bleomycin—melanoma	0.000117	0.00164	CcSEcCtD
Cisplatin—Oedema—Dactinomycin—melanoma	0.000116	0.00164	CcSEcCtD
Cisplatin—Malaise—Temozolomide—melanoma	0.000116	0.00164	CcSEcCtD
Cisplatin—Convulsion—Carmustine—melanoma	0.000116	0.00163	CcSEcCtD
Cisplatin—Infection—Dactinomycin—melanoma	0.000116	0.00163	CcSEcCtD
Cisplatin—Leukopenia—Temozolomide—melanoma	0.000115	0.00163	CcSEcCtD
Cisplatin—Thrombocytopenia—Dactinomycin—melanoma	0.000114	0.00161	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000114	0.0016	CcSEcCtD
Cisplatin—Myalgia—Carmustine—melanoma	0.000114	0.0016	CcSEcCtD
Cisplatin—Anxiety—Carmustine—melanoma	0.000113	0.0016	CcSEcCtD
Cisplatin—Paraesthesia—Bleomycin—melanoma	0.000112	0.00158	CcSEcCtD
Cisplatin—Convulsion—Temozolomide—melanoma	0.000112	0.00157	CcSEcCtD
Cisplatin—Dyspnoea—Bleomycin—melanoma	0.000111	0.00157	CcSEcCtD
Cisplatin—Anorexia—Dactinomycin—melanoma	0.000111	0.00156	CcSEcCtD
Cisplatin—ABCC2—lymph node—melanoma	0.00011	0.00286	CbGeAlD
Cisplatin—Myalgia—Temozolomide—melanoma	0.00011	0.00155	CcSEcCtD
Cisplatin—Anxiety—Temozolomide—melanoma	0.000109	0.00154	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000109	0.00154	CcSEcCtD
Cisplatin—Oedema—Carmustine—melanoma	0.000109	0.00153	CcSEcCtD
Cisplatin—Discomfort—Temozolomide—melanoma	0.000108	0.00153	CcSEcCtD
Cisplatin—Decreased appetite—Bleomycin—melanoma	0.000108	0.00153	CcSEcCtD
Cisplatin—Infection—Carmustine—melanoma	0.000108	0.00152	CcSEcCtD
Cisplatin—Acute coronary syndrome—Docetaxel—melanoma	0.000108	0.00152	CcSEcCtD
Cisplatin—Renal failure—Docetaxel—melanoma	0.000108	0.00152	CcSEcCtD
Cisplatin—Neuropathy peripheral—Docetaxel—melanoma	0.000108	0.00152	CcSEcCtD
Cisplatin—Myocardial infarction—Docetaxel—melanoma	0.000108	0.00152	CcSEcCtD
Cisplatin—Stomatitis—Docetaxel—melanoma	0.000107	0.00151	CcSEcCtD
Cisplatin—Pain—Bleomycin—melanoma	0.000107	0.0015	CcSEcCtD
Cisplatin—Conjunctivitis—Docetaxel—melanoma	0.000107	0.0015	CcSEcCtD
Cisplatin—Thrombocytopenia—Carmustine—melanoma	0.000107	0.0015	CcSEcCtD
Cisplatin—Tachycardia—Carmustine—melanoma	0.000106	0.0015	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000106	0.00149	CcSEcCtD
Cisplatin—CYP2B6—head—melanoma	0.000106	0.00275	CbGeAlD
Cisplatin—Oedema—Temozolomide—melanoma	0.000105	0.00148	CcSEcCtD
Cisplatin—Anaphylactic shock—Temozolomide—melanoma	0.000105	0.00148	CcSEcCtD
Cisplatin—Infection—Temozolomide—melanoma	0.000104	0.00147	CcSEcCtD
Cisplatin—Anorexia—Carmustine—melanoma	0.000104	0.00146	CcSEcCtD
Cisplatin—Hepatobiliary disease—Docetaxel—melanoma	0.000104	0.00146	CcSEcCtD
Cisplatin—Nervous system disorder—Temozolomide—melanoma	0.000103	0.00145	CcSEcCtD
Cisplatin—Thrombocytopenia—Temozolomide—melanoma	0.000103	0.00145	CcSEcCtD
Cisplatin—Feeling abnormal—Bleomycin—melanoma	0.000103	0.00145	CcSEcCtD
Cisplatin—Skin disorder—Temozolomide—melanoma	0.000102	0.00144	CcSEcCtD
Cisplatin—Hypotension—Carmustine—melanoma	0.000102	0.00143	CcSEcCtD
Cisplatin—Hyperhidrosis—Temozolomide—melanoma	0.000102	0.00143	CcSEcCtD
Cisplatin—Decreased appetite—Dactinomycin—melanoma	0.000101	0.00143	CcSEcCtD
Cisplatin—Anorexia—Temozolomide—melanoma	0.0001	0.00141	CcSEcCtD
Cisplatin—Pain—Dactinomycin—melanoma	9.94e-05	0.0014	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Carmustine—melanoma	9.92e-05	0.0014	CcSEcCtD
Cisplatin—ABCB1—retina—melanoma	9.87e-05	0.00256	CbGeAlD
Cisplatin—Body temperature increased—Bleomycin—melanoma	9.86e-05	0.00139	CcSEcCtD
Cisplatin—Paraesthesia—Carmustine—melanoma	9.77e-05	0.00138	CcSEcCtD
Cisplatin—Urinary tract disorder—Docetaxel—melanoma	9.72e-05	0.00137	CcSEcCtD
Cisplatin—Dyspnoea—Carmustine—melanoma	9.7e-05	0.00137	CcSEcCtD
Cisplatin—Connective tissue disorder—Docetaxel—melanoma	9.68e-05	0.00136	CcSEcCtD
Cisplatin—Urethral disorder—Docetaxel—melanoma	9.65e-05	0.00136	CcSEcCtD
Cisplatin—Feeling abnormal—Dactinomycin—melanoma	9.58e-05	0.00135	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Temozolomide—melanoma	9.58e-05	0.00135	CcSEcCtD
Cisplatin—Visual impairment—Docetaxel—melanoma	9.49e-05	0.00134	CcSEcCtD
Cisplatin—Decreased appetite—Carmustine—melanoma	9.46e-05	0.00133	CcSEcCtD
Cisplatin—Paraesthesia—Temozolomide—melanoma	9.45e-05	0.00133	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Carmustine—melanoma	9.4e-05	0.00132	CcSEcCtD
Cisplatin—Dyspnoea—Temozolomide—melanoma	9.38e-05	0.00132	CcSEcCtD
Cisplatin—Pain—Carmustine—melanoma	9.31e-05	0.00131	CcSEcCtD
Cisplatin—Eye disorder—Docetaxel—melanoma	9.2e-05	0.0013	CcSEcCtD
Cisplatin—Body temperature increased—Dactinomycin—melanoma	9.19e-05	0.0013	CcSEcCtD
Cisplatin—Hypersensitivity—Bleomycin—melanoma	9.19e-05	0.0013	CcSEcCtD
Cisplatin—Decreased appetite—Temozolomide—melanoma	9.14e-05	0.00129	CcSEcCtD
Cisplatin—PTGS2—head—melanoma	9.14e-05	0.00237	CbGeAlD
Cisplatin—Cardiac disorder—Docetaxel—melanoma	9.14e-05	0.00129	CcSEcCtD
Cisplatin—Flushing—Docetaxel—melanoma	9.14e-05	0.00129	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Temozolomide—melanoma	9.08e-05	0.00128	CcSEcCtD
Cisplatin—Pain—Temozolomide—melanoma	8.99e-05	0.00127	CcSEcCtD
Cisplatin—Feeling abnormal—Carmustine—melanoma	8.97e-05	0.00126	CcSEcCtD
Cisplatin—Asthenia—Bleomycin—melanoma	8.95e-05	0.00126	CcSEcCtD
Cisplatin—Immune system disorder—Docetaxel—melanoma	8.89e-05	0.00125	CcSEcCtD
Cisplatin—Mediastinal disorder—Docetaxel—melanoma	8.87e-05	0.00125	CcSEcCtD
Cisplatin—Arrhythmia—Docetaxel—melanoma	8.8e-05	0.00124	CcSEcCtD
Cisplatin—Alopecia—Docetaxel—melanoma	8.7e-05	0.00123	CcSEcCtD
Cisplatin—Feeling abnormal—Temozolomide—melanoma	8.67e-05	0.00122	CcSEcCtD
Cisplatin—Body temperature increased—Carmustine—melanoma	8.6e-05	0.00121	CcSEcCtD
Cisplatin—Malnutrition—Docetaxel—melanoma	8.57e-05	0.00121	CcSEcCtD
Cisplatin—Erythema—Docetaxel—melanoma	8.57e-05	0.00121	CcSEcCtD
Cisplatin—Hypersensitivity—Dactinomycin—melanoma	8.57e-05	0.00121	CcSEcCtD
Cisplatin—Asthenia—Dactinomycin—melanoma	8.34e-05	0.00118	CcSEcCtD
Cisplatin—Body temperature increased—Temozolomide—melanoma	8.32e-05	0.00117	CcSEcCtD
Cisplatin—BCHE—lymph node—melanoma	8.31e-05	0.00216	CbGeAlD
Cisplatin—Muscle spasms—Docetaxel—melanoma	8.24e-05	0.00116	CcSEcCtD
Cisplatin—ABCG2—lymph node—melanoma	8.03e-05	0.00208	CbGeAlD
Cisplatin—Hypersensitivity—Carmustine—melanoma	8.02e-05	0.00113	CcSEcCtD
Cisplatin—Diarrhoea—Dactinomycin—melanoma	7.96e-05	0.00112	CcSEcCtD
Cisplatin—Vomiting—Bleomycin—melanoma	7.93e-05	0.00112	CcSEcCtD
Cisplatin—Anaemia—Docetaxel—melanoma	7.92e-05	0.00112	CcSEcCtD
Cisplatin—ABCB1—mammalian vulva—melanoma	7.9e-05	0.00205	CbGeAlD
Cisplatin—Rash—Bleomycin—melanoma	7.86e-05	0.00111	CcSEcCtD
Cisplatin—Dermatitis—Bleomycin—melanoma	7.86e-05	0.00111	CcSEcCtD
Cisplatin—Asthenia—Carmustine—melanoma	7.81e-05	0.0011	CcSEcCtD
Cisplatin—Hypersensitivity—Temozolomide—melanoma	7.75e-05	0.00109	CcSEcCtD
Cisplatin—Leukopenia—Docetaxel—melanoma	7.67e-05	0.00108	CcSEcCtD
Cisplatin—Asthenia—Temozolomide—melanoma	7.55e-05	0.00106	CcSEcCtD
Cisplatin—Diarrhoea—Carmustine—melanoma	7.45e-05	0.00105	CcSEcCtD
Cisplatin—Convulsion—Docetaxel—melanoma	7.43e-05	0.00105	CcSEcCtD
Cisplatin—Nausea—Bleomycin—melanoma	7.41e-05	0.00104	CcSEcCtD
Cisplatin—Vomiting—Dactinomycin—melanoma	7.39e-05	0.00104	CcSEcCtD
Cisplatin—Rash—Dactinomycin—melanoma	7.33e-05	0.00103	CcSEcCtD
Cisplatin—Myalgia—Docetaxel—melanoma	7.3e-05	0.00103	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	7.25e-05	0.00102	CcSEcCtD
Cisplatin—Diarrhoea—Temozolomide—melanoma	7.2e-05	0.00101	CcSEcCtD
Cisplatin—Anaphylactic shock—Docetaxel—melanoma	7e-05	0.000986	CcSEcCtD
Cisplatin—Oedema—Docetaxel—melanoma	7e-05	0.000986	CcSEcCtD
Cisplatin—Infection—Docetaxel—melanoma	6.95e-05	0.00098	CcSEcCtD
Cisplatin—Vomiting—Carmustine—melanoma	6.92e-05	0.000976	CcSEcCtD
Cisplatin—Nausea—Dactinomycin—melanoma	6.91e-05	0.000974	CcSEcCtD
Cisplatin—Rash—Carmustine—melanoma	6.86e-05	0.000968	CcSEcCtD
Cisplatin—Nervous system disorder—Docetaxel—melanoma	6.86e-05	0.000967	CcSEcCtD
Cisplatin—Dermatitis—Carmustine—melanoma	6.86e-05	0.000967	CcSEcCtD
Cisplatin—Thrombocytopenia—Docetaxel—melanoma	6.85e-05	0.000966	CcSEcCtD
Cisplatin—Tachycardia—Docetaxel—melanoma	6.83e-05	0.000963	CcSEcCtD
Cisplatin—Skin disorder—Docetaxel—melanoma	6.79e-05	0.000958	CcSEcCtD
Cisplatin—Vomiting—Temozolomide—melanoma	6.69e-05	0.000943	CcSEcCtD
Cisplatin—Anorexia—Docetaxel—melanoma	6.67e-05	0.00094	CcSEcCtD
Cisplatin—Rash—Temozolomide—melanoma	6.63e-05	0.000935	CcSEcCtD
Cisplatin—Dermatitis—Temozolomide—melanoma	6.63e-05	0.000934	CcSEcCtD
Cisplatin—Hypotension—Docetaxel—melanoma	6.54e-05	0.000922	CcSEcCtD
Cisplatin—Nausea—Carmustine—melanoma	6.47e-05	0.000912	CcSEcCtD
Cisplatin—PTGS2—lymph node—melanoma	6.4e-05	0.00166	CbGeAlD
Cisplatin—Musculoskeletal discomfort—Docetaxel—melanoma	6.37e-05	0.000899	CcSEcCtD
Cisplatin—Paraesthesia—Docetaxel—melanoma	6.28e-05	0.000886	CcSEcCtD
Cisplatin—Nausea—Temozolomide—melanoma	6.25e-05	0.000881	CcSEcCtD
Cisplatin—Dyspnoea—Docetaxel—melanoma	6.24e-05	0.000879	CcSEcCtD
Cisplatin—Decreased appetite—Docetaxel—melanoma	6.08e-05	0.000857	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Docetaxel—melanoma	6.04e-05	0.000851	CcSEcCtD
Cisplatin—Pain—Docetaxel—melanoma	5.98e-05	0.000843	CcSEcCtD
Cisplatin—Feeling abnormal—Docetaxel—melanoma	5.76e-05	0.000813	CcSEcCtD
Cisplatin—ABCB1—head—melanoma	5.66e-05	0.00147	CbGeAlD
Cisplatin—Body temperature increased—Docetaxel—melanoma	5.53e-05	0.00078	CcSEcCtD
Cisplatin—Hypersensitivity—Docetaxel—melanoma	5.15e-05	0.000727	CcSEcCtD
Cisplatin—Asthenia—Docetaxel—melanoma	5.02e-05	0.000708	CcSEcCtD
Cisplatin—Diarrhoea—Docetaxel—melanoma	4.79e-05	0.000675	CcSEcCtD
Cisplatin—Vomiting—Docetaxel—melanoma	4.45e-05	0.000627	CcSEcCtD
Cisplatin—Rash—Docetaxel—melanoma	4.41e-05	0.000622	CcSEcCtD
Cisplatin—Dermatitis—Docetaxel—melanoma	4.41e-05	0.000621	CcSEcCtD
Cisplatin—Nausea—Docetaxel—melanoma	4.15e-05	0.000586	CcSEcCtD
Cisplatin—ABCB1—lymph node—melanoma	3.96e-05	0.00103	CbGeAlD
Cisplatin—ABCC5—Disease—CDKN1B—melanoma	3.16e-06	4.09e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP1B1—melanoma	3.15e-06	4.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FASN—melanoma	3.15e-06	4.08e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GPAM—melanoma	3.14e-06	4.07e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CUBN—melanoma	3.14e-06	4.06e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP1B1—melanoma	3.12e-06	4.04e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.09e-06	4.01e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.08e-06	3.99e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PPARG—melanoma	3.08e-06	3.99e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.08e-06	3.99e-05	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—AKT1—melanoma	3.06e-06	3.96e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SDHD—melanoma	3.03e-06	3.93e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CSPG4—melanoma	3.03e-06	3.93e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—BSG—melanoma	3.03e-06	3.93e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FOXO4—melanoma	3.03e-06	3.92e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HDAC2—melanoma	3.03e-06	3.92e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CXCR4—melanoma	3.03e-06	3.92e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD44—melanoma	3e-06	3.88e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3e-06	3.88e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CTNNB1—melanoma	2.99e-06	3.87e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CXCL8—melanoma	2.96e-06	3.84e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CB—melanoma	2.94e-06	3.81e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GPAM—melanoma	2.94e-06	3.8e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.93e-06	3.79e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	2.93e-06	3.79e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	2.93e-06	3.79e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN1A—melanoma	2.92e-06	3.78e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—melanoma	2.92e-06	3.78e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTEN—melanoma	2.91e-06	3.77e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTEN—melanoma	2.91e-06	3.77e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ABCB1—melanoma	2.88e-06	3.73e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP17A1—melanoma	2.86e-06	3.7e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.85e-06	3.69e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTEN—melanoma	2.84e-06	3.67e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CB—melanoma	2.82e-06	3.65e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.82e-06	3.65e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CD—melanoma	2.81e-06	3.63e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—melanoma	2.8e-06	3.62e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.79e-06	3.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.78e-06	3.6e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ALB—melanoma	2.77e-06	3.59e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.77e-06	3.58e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT3—melanoma	2.76e-06	3.58e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP17A1—melanoma	2.75e-06	3.56e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CTNNB1—melanoma	2.73e-06	3.54e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CG—melanoma	2.72e-06	3.51e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GNA11—melanoma	2.7e-06	3.49e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PLA2G6—melanoma	2.67e-06	3.46e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PRKCA—melanoma	2.65e-06	3.43e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—FASN—melanoma	2.64e-06	3.42e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ERCC2—melanoma	2.63e-06	3.4e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PPARG—melanoma	2.62e-06	3.39e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—STAT3—melanoma	2.6e-06	3.37e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NRAS—melanoma	2.6e-06	3.36e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SLC5A5—melanoma	2.6e-06	3.36e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ABCB1—melanoma	2.6e-06	3.36e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GNA11—melanoma	2.59e-06	3.36e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ABCB1—melanoma	2.57e-06	3.33e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTEN—melanoma	2.54e-06	3.29e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.54e-06	3.29e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—FASN—melanoma	2.54e-06	3.29e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CD44—melanoma	2.51e-06	3.25e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GNAQ—melanoma	2.51e-06	3.25e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PLA2G6—melanoma	2.5e-06	3.23e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SLC5A5—melanoma	2.5e-06	3.23e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MAPK3—melanoma	2.49e-06	3.22e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.46e-06	3.18e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.46e-06	3.18e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CB—melanoma	2.45e-06	3.17e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB4—melanoma	2.44e-06	3.16e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTEN—melanoma	2.44e-06	3.16e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—melanoma	2.42e-06	3.14e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN2B—melanoma	2.42e-06	3.13e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—melanoma	2.42e-06	3.13e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PIK3CA—melanoma	2.41e-06	3.13e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GNAQ—melanoma	2.41e-06	3.12e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CD44—melanoma	2.41e-06	3.12e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP1B1—melanoma	2.41e-06	3.11e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—VCAN—melanoma	2.4e-06	3.11e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PRKCA—melanoma	2.39e-06	3.09e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CD—melanoma	2.39e-06	3.09e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ERCC2—melanoma	2.37e-06	3.07e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MAPK1—melanoma	2.37e-06	3.06e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—melanoma	2.37e-06	3.06e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PRKCA—melanoma	2.37e-06	3.06e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ALB—melanoma	2.36e-06	3.05e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ERCC2—melanoma	2.35e-06	3.04e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD86—melanoma	2.34e-06	3.03e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP1B1—melanoma	2.31e-06	2.99e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGF1—melanoma	2.27e-06	2.94e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—VCAN—melanoma	2.24e-06	2.9e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—melanoma	2.24e-06	2.89e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PDGFRA—melanoma	2.2e-06	2.85e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PRKCA—melanoma	2.18e-06	2.82e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.18e-06	2.82e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERCC2—melanoma	2.16e-06	2.79e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAP2K2—melanoma	2.13e-06	2.75e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.12e-06	2.75e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.12e-06	2.75e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTEN—melanoma	2.11e-06	2.74e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CB—melanoma	2.08e-06	2.69e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.08e-06	2.69e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CG—melanoma	2.07e-06	2.69e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—melanoma	2.06e-06	2.67e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CA—melanoma	2.05e-06	2.66e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CA—melanoma	2.05e-06	2.66e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.05e-06	2.65e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP17A1—melanoma	2.03e-06	2.62e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TERT—melanoma	2.02e-06	2.62e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HLA-A—melanoma	2.02e-06	2.62e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RAC1—melanoma	2.02e-06	2.61e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPARG—melanoma	2e-06	2.59e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CA—melanoma	2e-06	2.59e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ABCB1—melanoma	1.98e-06	2.56e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—melanoma	1.97e-06	2.55e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HIF1A—melanoma	1.94e-06	2.51e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GNA11—melanoma	1.91e-06	2.48e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ABCB1—melanoma	1.9e-06	2.46e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—melanoma	1.9e-06	2.46e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP17A1—melanoma	1.89e-06	2.45e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.88e-06	2.43e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CG—melanoma	1.87e-06	2.42e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—FASN—melanoma	1.87e-06	2.42e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.87e-06	2.42e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CG—melanoma	1.85e-06	2.4e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.84e-06	2.39e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC5A5—melanoma	1.84e-06	2.38e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CD—melanoma	1.82e-06	2.36e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PRKCA—melanoma	1.82e-06	2.36e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—melanoma	1.82e-06	2.35e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ERCC2—melanoma	1.81e-06	2.34e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARG—melanoma	1.81e-06	2.34e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ALB—melanoma	1.8e-06	2.33e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTEN—melanoma	1.8e-06	2.33e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CA—melanoma	1.79e-06	2.32e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARG—melanoma	1.79e-06	2.31e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GNA11—melanoma	1.79e-06	2.31e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GNAQ—melanoma	1.78e-06	2.3e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CD44—melanoma	1.78e-06	2.3e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS2—melanoma	1.76e-06	2.28e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PRKCA—melanoma	1.75e-06	2.27e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—FASN—melanoma	1.75e-06	2.26e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOTCH1—melanoma	1.74e-06	2.26e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ERCC2—melanoma	1.74e-06	2.25e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CA—melanoma	1.72e-06	2.23e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC5A5—melanoma	1.72e-06	2.23e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD80—melanoma	1.71e-06	2.21e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1B1—melanoma	1.71e-06	2.21e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KIT—melanoma	1.71e-06	2.21e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APC—melanoma	1.71e-06	2.21e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGF—melanoma	1.69e-06	2.18e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—melanoma	1.68e-06	2.17e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—melanoma	1.68e-06	2.17e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GNAQ—melanoma	1.66e-06	2.15e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CD44—melanoma	1.66e-06	2.15e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CD—melanoma	1.65e-06	2.13e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—melanoma	1.63e-06	2.12e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CD—melanoma	1.63e-06	2.11e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.63e-06	2.11e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ALB—melanoma	1.62e-06	2.1e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.61e-06	2.09e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ALB—melanoma	1.61e-06	2.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BRAF—melanoma	1.6e-06	2.07e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1B1—melanoma	1.59e-06	2.06e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CB—melanoma	1.59e-06	2.06e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—melanoma	1.58e-06	2.04e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAP2K1—melanoma	1.51e-06	1.95e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CD—melanoma	1.5e-06	1.94e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.5e-06	1.94e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CA—melanoma	1.49e-06	1.93e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—melanoma	1.47e-06	1.9e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGF2—melanoma	1.44e-06	1.86e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CB—melanoma	1.43e-06	1.86e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CG—melanoma	1.43e-06	1.85e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—melanoma	1.42e-06	1.84e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CB—melanoma	1.42e-06	1.84e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—melanoma	1.41e-06	1.82e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.41e-06	1.82e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—melanoma	1.41e-06	1.82e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARG—melanoma	1.38e-06	1.78e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTEN—melanoma	1.37e-06	1.78e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CG—melanoma	1.37e-06	1.78e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MDM2—melanoma	1.34e-06	1.74e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARG—melanoma	1.32e-06	1.71e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB2—melanoma	1.32e-06	1.71e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCB1—melanoma	1.31e-06	1.7e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CB—melanoma	1.31e-06	1.69e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD4—melanoma	1.3e-06	1.69e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PRKCA—melanoma	1.29e-06	1.67e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ERCC2—melanoma	1.28e-06	1.66e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CA—melanoma	1.27e-06	1.64e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CD—melanoma	1.26e-06	1.62e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTEN—melanoma	1.24e-06	1.6e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ALB—melanoma	1.24e-06	1.6e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTEN—melanoma	1.23e-06	1.59e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1B—melanoma	1.23e-06	1.59e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—melanoma	1.22e-06	1.58e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PRKCA—melanoma	1.21e-06	1.56e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CD—melanoma	1.21e-06	1.56e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ERCC2—melanoma	1.2e-06	1.55e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ALB—melanoma	1.19e-06	1.54e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CTNNB1—melanoma	1.16e-06	1.5e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1A—melanoma	1.13e-06	1.46e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTEN—melanoma	1.13e-06	1.46e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CB—melanoma	1.09e-06	1.42e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CB—melanoma	1.05e-06	1.36e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—melanoma	1.04e-06	1.35e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—melanoma	1.04e-06	1.34e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CG—melanoma	1.01e-06	1.31e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—melanoma	1.01e-06	1.31e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRAS—melanoma	1.01e-06	1.3e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.92e-07	1.28e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARG—melanoma	9.77e-07	1.26e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CA—melanoma	9.69e-07	1.25e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAPK3—melanoma	9.65e-07	1.25e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CG—melanoma	9.46e-07	1.22e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTEN—melanoma	9.45e-07	1.22e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—melanoma	9.38e-07	1.21e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAPK1—melanoma	9.18e-07	1.19e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—melanoma	9.18e-07	1.19e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARG—melanoma	9.13e-07	1.18e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTEN—melanoma	9.09e-07	1.18e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CD—melanoma	8.9e-07	1.15e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALB—melanoma	8.78e-07	1.14e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CA—melanoma	8.75e-07	1.13e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—melanoma	8.67e-07	1.12e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CA—melanoma	8.65e-07	1.12e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CD—melanoma	8.31e-07	1.08e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALB—melanoma	8.21e-07	1.06e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CA—melanoma	7.96e-07	1.03e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—melanoma	7.92e-07	1.02e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CB—melanoma	7.76e-07	1e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—melanoma	7.69e-07	9.95e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—melanoma	7.37e-07	9.54e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CB—melanoma	7.25e-07	9.38e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—melanoma	7.18e-07	9.29e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—melanoma	7.14e-07	9.25e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—melanoma	7.07e-07	9.15e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—melanoma	7.05e-07	9.13e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTEN—melanoma	6.7e-07	8.68e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CA—melanoma	6.67e-07	8.63e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—melanoma	6.51e-07	8.42e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CA—melanoma	6.41e-07	8.3e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTEN—melanoma	6.26e-07	8.1e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—melanoma	5.45e-07	7.05e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—melanoma	5.24e-07	6.78e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CA—melanoma	4.73e-07	6.12e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CA—melanoma	4.42e-07	5.72e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—melanoma	3.86e-07	5e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—melanoma	3.61e-07	4.67e-06	CbGpPWpGaD
